CFTR and cystic fibrosis: In contrast to this, Halilbasic et al. reported lower plasma S1P levels in cystic fibrosis patients compared to healthy controls [42], however, the researchers found higher concentrations of unbound S1P in patients with the dF508-homozygous mutation compared to patients with a heterozygous dF508 CFTR mutation.